News

Management of Musculoskeletal Issues in Hemophiliacs at a Glance

17. 5. 2022 Source: Hemophilia with Movement

Musculoskeletal issues are among the most common complications of hemophilia. Prevention and early treatment are crucial, and this message is also addressed to specialists by the World Federation of Hemophilia (WFH) guidelines from 2020.

Progress on Lorlatinib –⁠ What's Next?

Lorlatinib is currently mainly used in the 2nd and later lines of treatment for non-small cell lung cancer (NSCLC) with ALK gene rearrangement. Clinical research is now focusing on the question of…

17. 5. 2022 Source: Genetic Profile and Treatment of NSCLC

Debate on Sepsis Biomarkers 'on Blood'

Sepsis represents a major cause of death from infectious diseases. Early identification of patients with a prognosis of sepsis is therefore crucial for their survival and prognosis. In addition to…

16. 5. 2022 Source: Because

Current and Future Possibilities for Influencing Immune Thrombocytopenia

The possibilities for treating immune thrombocytopenia (ITP) are quite broad today, with a major advancement for many patients being the advent of thrombopoietin receptor agonists. However, for some…

16. 5. 2022 Source: Immune Thrombocytopenia

Romiplostim in a Pregnant Woman −⁠ Case Report

The following clinical case demonstrates good control of resistant immune thrombocytopenia in a pregnant woman during the administration of romiplostim.

16. 5. 2022 Source: Immune Thrombocytopenia

ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration 2022

For the second time, a two-day meeting titled "ID 360 –⁠ Immunodeficiency in Interdisciplinary Collaboration" took place, this time on March 25–26, 2022, in Prague. Several current topics were…

13. 5. 2022 Source: Primary and Secondary Immunodeficiencies

According to which parameters can we best assess the quality of incontinence aids?

Properly chosen incontinence aid significantly influences the user's quality of life. When selecting incontinence aids, it is very important to consider their individual properties and parameters.…

12. 5. 2022 Source: Incontinence

Inkontinence_inkontinenční_pomůcky_únik_moči

Correct Selection of Appropriate Incontinence Aid is Crucial for Addressing Patient's Difficulties

Urinary incontinence is an uncomfortable issue that can be resolved by choosing the right incontinence aids. Selecting a quality product is most important for the patient −⁠ it affects their comfort…

12. 5. 2022 Source: Incontinence

Experience from Clinical Practice with Intestinal Gel LECIG in Treating Parkinson's Disease

A Swedish observational study evaluated the applicability of the LECIG intestinal gel, which contains levodopa (20 mg/ml), carbidopa (5 mg/ml), and entacapone (20 mg/ml), in clinical practice for…

12. 5. 2022 Source: Parkinson's Disease

Eletriptan and Its Role in Acute Migraine Therapy

In the acute treatment of moderate to severe migraine attacks, medications from the triptan group are primarily used. The following article summarizes important findings about eletriptan and its key…

10. 5. 2022 Source: Treatment of Severe Migraine

Efficacy and Safety of Bimekizumab in the Treatment of Moderate to Severe Plaque Psoriasis -⁠ BE READY Study Results

The interleukin 17 (IL-17) family represents a group of pro-inflammatory cytokines that play a crucial role in the pathogenesis of psoriasis. Inhibiting interleukins from this family has a…

6. 5. 2022 Source: Psoriasis

Current View on the Issue of Protein Intake in Critically Ill Patients

A summary of current knowledge and guidelines concerning the nutritional needs of critically ill patients presented last year in the journal Clinical Nutrition deals with protein intake, specifically…

5. 5. 2022 Source: Parenteral Nutrition

Reduction of Mortality in Patients After Abdominal Surgery in Critical Condition Thanks to Early Supplemental Parenteral Nutrition

Ensuring adequate nutrition is an important part of therapy for critically ill patients to achieve better clinical outcomes in terms of both survival and recovery speed. The preferred option is…

5. 5. 2022 Source: Parenteral Nutrition

Empagliflozin Secures Reimbursement for Heart Failure Treatment

Starting May 1st, health insurance companies will cover Jardiance^® (empagliflozin) for patients with heart failure with reduced ejection fraction. Cardiologists, pediatric cardiologists,…

3. 5. 2022 Source: Heart Failure

Gut-Brain Axis −⁠ Future of MS Treatment?

The relationship between the gut microbiome and multiple sclerosis has been a major topic recently. How far has current science progressed in decoding this issue? A recent review article published in…

3. 5. 2022 Source: Multiple Sclerosis

1 … 53 54 55 56 57 … 115

Back Filter by speciality

Remove filters